Amrutanjan Health Care Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 8, 2026
- Posted by: Harsh Piplani
- Category: Results
Amrutanjan Health Care share price Rs 500.45 on 8 September 2026, up 0.03%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 4.37 crore. Q2 FY26 base a profit of Rs 13.96 crore.
Quick Answer
The Amrutanjan Health Care Q2 results date for FY27 is not confirmed, and Amrutanjan Health Care Ltd. had not filed a board meeting intimation with the NSE or BSE as of 8 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 117.70 crore in revenue and a profit of Rs 13.96 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Amrutanjan Health Care Q2 results FY27 announcement is the next scheduled earnings event for Amrutanjan Health Care Ltd., a consumer healthcare company known for pain balms and the Comfy range of feminine hygiene products, alongside beverages and health drinks. The stock traded at Rs 500.45 on the NSE on 8 September 2026, up 0.03% from the previous close of Rs 500.30, about 36.7% below its 52-week high of Rs 790.95 and 3.7% above its 52-week low of Rs 482.80.
What makes the Amrutanjan Health Care Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 117.70 crore of revenue and a profit of Rs 13.96 crore, while the most recent quarter on record, Q1 FY27, produced Rs 102.97 crore and a profit of Rs 4.37 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Amrutanjan Health Care Q2 Results FY27 Date?
The Amrutanjan Health Care Q2 results date for FY27 is not confirmed. As of 8 September 2026, Amrutanjan Health Care Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Amrutanjan Health Care Q2 results date becomes public through that filing rather than through any advance announcement.
The Amrutanjan Health Care Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Amrutanjan Health Care.
Amrutanjan Health Care Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Amrutanjan Health Care Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Amrutanjan Health Care. The Amrutanjan Health Care Q2 results watchlist below is built from what the company has actually reported and disclosed.
The first is the seasonal shape. Amrutanjan Health Care sells pain balms and cold remedies that move with the winter months, so June is structurally its weakest quarter and September marks the start of the recovery.
The second is the margin swing that comes with it. Operating margin was 6.06% in Q1 FY27 against 14.04% in the September 2025 quarter, and that gap is mostly fixed-cost absorption rather than a change in pricing.
The third is the Comfy feminine hygiene business, which is less seasonal than the balm portfolio. Its share of revenue is what would eventually reduce the swing between the strongest and weakest quarters.
Check Amrutanjan Health Care Ltd. Live Fundamentals on the Univest Screener
Amrutanjan Health Care Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Amrutanjan Health Care Ltd. reported revenue of Rs 102.97 crore in Q1 FY27, up 9.48% from Rs 94.05 crore in Q1 FY26, and a profit of Rs 4.37 crore at the net level, down 47.41% from Rs 8.31 crore in Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was down 31.25% over the March 2026 quarter figure of Rs 149.77 crore, and net profit was down 73.01% from Rs 16.19 crore in Q4 FY26. Operating margin stood at 6.06% in Q1 FY27 against 14.04% in the September 2025 quarter, which is the comparison the Amrutanjan Health Care Q2 results print will be read against.
Q2 FY26 Base: The Comparison Amrutanjan Health Care Q2 Results FY27 Must Beat
Amrutanjan Health Care Ltd. reported revenue of Rs 117.70 crore and a profit of Rs 13.96 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Amrutanjan Health Care Q2 results preview.
Net profit in that base quarter was above the Rs 4.37 crore just reported for Q1 FY27, so the year-on-year comparison starts from a demanding level. Revenue of Rs 117.70 crore sits above the Rs 102.97 crore of the June 2026 quarter, which frames how much sequential movement the Amrutanjan Health Care Q2 results print needs to show growth.
Amrutanjan Health Care Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 117.70 | 13.96 |
| Q3 FY26 (Dec 2025) | 141.04 | 19.45 |
| Q4 FY26 (Mar 2026) | 149.77 | 16.19 |
| Q1 FY27 (Jun 2026) | 102.97 | 4.37 |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Amrutanjan Health Care Q2 results preview uses.
Revenue across those four quarters ranged from Rs 102.97 crore to Rs 149.77 crore, and net profit from Rs 4.37 crore to Rs 19.45 crore. That spread is the honest context for the Amrutanjan Health Care Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Amrutanjan Health Care Q2 Results FY27
The Amrutanjan Health Care Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Amrutanjan Health Care has already reported.
Seasonality in Pain Balms
Revenue rose from Rs 94.05 crore in June 2025 to Rs 149.77 crore by March 2026 before falling back to Rs 102.97 crore in June 2026. That shape repeats annually and is the single most important context for reading any one quarter.
Beverage and Hygiene Diversification
The beverages and feminine hygiene lines were added to broaden the portfolio beyond balms. Their contribution decides whether the September quarter shows real growth or simply seasonal normalisation.
Debt-Free With Strong Returns
Amrutanjan Health Care carries a debt-to-equity ratio of 0.00 and a return on equity of 18.40%, trading at a price-to-earnings ratio of 26.75 against a sector average of 50.83. The stock sits near its 52-week low of Rs 482.80.
Amrutanjan Health Care Q2 Results FY27: Share Price and Valuation Going Into the Print
Amrutanjan Health Care share price today is Rs 500.45 on the NSE, up Rs 0.15 or 0.03% from the previous close of Rs 500.30 on 8 September 2026, ahead of the Amrutanjan Health Care Q2 results announcement.
| Metric | Value (8 September 2026) |
|---|---|
| NSE Symbol | AMRUTANJAN |
| Current Market Price | Rs 500.45 |
| 52-Week High | Rs 790.95 |
| 52-Week Low | Rs 482.80 |
| Market Capitalisation | Rs 1,444 crore |
| PE Ratio | 26.75 |
| Sector PE | 50.83 |
| PB Ratio | 3.90 |
| EPS (TTM) | Rs 18.67 |
| Book Value per Share | Rs 128.06 |
| Debt to Equity | 0.00 |
| Return on Equity | 18.40% |
| 50-Day Moving Average | Rs 520.33 |
| 200-Day Moving Average | Rs 574.65 |
| RSI (14) | 51.06 |
The stock trades below both its 50-day average of Rs 520.33 and its 200-day average of Rs 574.65, with a 14-day RSI of 51.06. None of this is a view on where the shares go once the Amrutanjan Health Care Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Amrutanjan Health Care Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Amrutanjan Health Care Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Amrutanjan Health Care Q2 results print in proportion.
- Revenue against the Rs 117.70 crore reported in the September 2025 base quarter
- Net profit against a profit of Rs 13.96 crore in that same quarter
- Operating margin against 6.06% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Amrutanjan Health Care Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Amrutanjan Health Care Q2 Results FY27
The Amrutanjan Health Care Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Amrutanjan Health Care Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Amrutanjan Health Care Q2 results FY27 print faces a base of Rs 117.70 crore in revenue and a profit of Rs 13.96 crore, with the most recent quarter having delivered Rs 102.97 crore and a profit of Rs 4.37 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Amrutanjan Health Care, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Amrutanjan Health Care Q2 Results FY27
What is the Amrutanjan Health Care Q2 results date for FY27?
Ans. The Amrutanjan Health Care Q2 results date for FY27 is not confirmed. Amrutanjan Health Care Ltd. had not filed a board meeting intimation with the NSE or BSE as of 8 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Amrutanjan Health Care Q2 results 2026 cover?
Ans. The Amrutanjan Health Care Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Amrutanjan Health Care Ltd. reports revenue, operating profit and net profit for that period, and the Amrutanjan Health Care Q2 results filing also carries the notes to the accounts.
What were the Amrutanjan Health Care Q1 FY27 results?
Ans. Amrutanjan Health Care Ltd. reported revenue of Rs 102.97 crore in Q1 FY27 and a profit of Rs 4.37 crore at the net level. Revenue was up 9.48% versus Q1 FY26 and net profit was down 47.41% from Rs 8.31 crore in Q1 FY26.
What were Amrutanjan Health Care Q2 FY26 results in the September 2025 quarter?
Ans. Amrutanjan Health Care Ltd. reported revenue of Rs 117.70 crore and a profit of Rs 13.96 crore in Q2 FY26. Operating margin was 14.04%. Those figures form the base for the Amrutanjan Health Care Q2 results FY27 comparison.
What are the main Amrutanjan Health Care Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Amrutanjan Health Care Q2 results expectations centre on revenue against the Rs 117.70 crore base, net profit against a profit of Rs 13.96 crore, operating margin against 6.06% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Amrutanjan Health Care share price today ahead of the Q2 earnings?
Ans. Amrutanjan Health Care share price is Rs 500.45 on the NSE as of 8 September 2026, up 0.03% from Rs 500.30. The stock is about 36.7% below its 52-week high of Rs 790.95 and 3.7% above its 52-week low of Rs 482.80, at a market capitalisation of Rs 1,444 crore.
Is Amrutanjan Health Care a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Amrutanjan Health Care Ltd.. The stock trades at a price-to-book ratio of 3.90 with a return on equity of 18.40%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
